Companies

Waldencast plc

WALD, WALDW · CIK 0001840199 · operating

$0.04-0.25%Last updated Mar 3, 8:57 PM

Key Statistics

Valuation

Market Cap
P/E
Fwd P/E
PEG
P/S
P/B0.01
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE26.32%
ROA-4.16%
FCF Margin

Financial Health

Current Ratio4.64
Debt/Equity-1.03
Free Cash Flow-$815,682
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta-0.45
52W High$0.168
52W Low$0.022

About Waldencast plc

Waldencast plc operates in the beauty and personal care sector, offering skincare and cosmetics products across multiple geographic markets including North America, Europe, the Middle East, India, and Australia-New Zealand. The company's product portfolio spans medical-grade skincare targeting signs of aging, hyperpigmentation, and skin texture concerns, as well as color cosmetics including foundations, concealers, eyeshadow, lip color, and related products. Distribution occurs through multiple channels: retail partnerships, physician networks, direct-to-consumer e-commerce platforms, and third-party logistics providers.

The business operates through two distinct segments: Obagi Medical, which focuses on clinical skincare solutions, and Milk Makeup, which addresses the mainstream cosmetics market. This dual-segment structure allows the company to serve both professional and consumer channels across different price points and product categories.

Headquartered in London, Waldencast employs approximately 335 full-time staff and maintains operations across established and emerging markets in North America, Europe, the Middle East, India, and Asia-Pacific regions. The company was incorporated in 2020 and is listed on Nasdaq.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2021

Annual Reports (10-K) · 1 filings

Report DateFiledAccession Number
2021-12-312022-03-310001213900-22-016813SEC ↗